Inspire Medical Systems, Inc.

NYSE:INSP

Medical - Devices

Healthcare
$58.11 +1.24%

+$0.51 today

Market cap
$1.68B
Beta
0.73
P/E (TTM)
9.1
EPS (TTM)
$4.57
52W Low $38.91High $147.03

Volume 0.51M

Average 1.13M

INSP Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Inspire Medical Systems, Inc.NYSE: INSP

Operating Expenses · Q2 FY2026 · quarter ended Jun 2026

Operating expenses dips below year-ago levels

Q2 FY2026 operating expenses of $171.97M fell 7.4% year over year, behind the +4.9% change in trailing-twelve-month operating expenses. Sequentially, it fell 3.4% from the prior quarter. Over 3 fiscal years it compounded at +23.2% a year.

Context

  • Operating expenses amounted to 79.8% of revenue in FY2025, down 0.4 pp from a year earlier.
  • Operating expenses increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -7.4% toward the trailing-twelve-month pace of +4.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$171.97M-3.4% QoQ
Last fiscal yearDec 2025
$727.8M+13.1% YoY
LTMJun 2026
$719.98M+4.9% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.4%——
1 year+13.1%——
3-year CAGR+23.2%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
727.8M USD
Year-over-year change
+13.1%
4-year CAGR
+32.0%

Operating Expenses vs competitors

How INSP compares with its peers on the latest reported figures

  • INSP's LTM Jun 2026 operating expenses of $719.98M is the 2nd highest of the 9 companies compared; the peer median is $287.18M.
  • Its year-over-year change of +4.9% is the 6th highest of 9, against a peer median of +8.9%.
  • Operating expenses amounts to 80.1% of revenue for INSP, versus a peer median of 42.3%.
INSP Competitors Peer median
Operating Expenses for INSP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ARDTArdent Health Partners, LLCLTM Mar 2026$2.62B -38.8%+13.9%40.7%
INSPInspire Medical Systems, Inc.LTM Jun 2026$719.98M +4.9%+23.2%80.1%
RCUSArcus Biosciences, Inc.LTM Jun 2026$596M -0.7%+16.7%509.4%
ADUSAddus HomeCare CorporationLTM Jun 2026$329.53M +10.2%+11.9%22.3%
PRCTPROCEPT BioRobotics CorporationLTM Mar 2026$311.83M +23.4%+36.6%96.8%
ITGRInteger Holdings CorporationLTM Jul 2026$262.52M +15.1%-2.5%14.3%
AORTArtivion, Inc.LTM Mar 2026$253.12M +8.3%+7.5%55.2%
BKDBrookdale Senior Living Inc.LTM Sep 2026$218.59M -74.6%+4.1%7.4%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$112.45M +9.6%+12.3%43.9%
Peer median (excluding INSP) $287.18M+8.9%+12.1%42.3%

Competitors are the stored peer set for INSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue233.39M407.86M624.8M802.8M911.98M
Cost of Revenue33.28M66.12M96.58M122.99M133.23M
Gross Profit200.12M341.74M528.22M679.82M778.76M
Gross Margin85.7%83.8%84.5%84.7%85.4%
Research & Development37.35M68.65M116.54M114.13M103.17M
Selling, General & Admin202.62M320.69M451.96M529.61M624.64M
Operating Expenses239.97M389.33M568.49M643.74M727.8M
Depreciation & Amortization1.22M1.86M2.85M6.55M13.96M
EBITDA(38.62M)(40.73M)(17.06M)65.03M79.79M
EBITDA Margin-16.5%-10.0%-2.7%8.1%8.7%
Operating Income(39.85M)(47.59M)(40.27M)36.08M50.95M
Operating Margin-17.1%-11.7%-6.4%4.5%5.6%
Interest Income125K5.05M20.56M23.25M17.54M
Interest Expense2.13M1.68M022K137K
Other Income / Expenses(2.12M)3.32M20.37M22.37M14.74M
Income Before Tax(41.97M)(44.27M)(19.91M)58.45M65.7M
Pre-Tax Margin-18.0%-10.9%-3.2%7.3%7.2%
Income Tax Expense72K613K1.25M4.94M(79.73M)
Net Income(42.04M)(44.88M)(21.15M)53.51M145.42M
Net Margin-18.0%-11.0%-3.4%6.7%15.9%
EPS (Basic)(1.54)(1.60)(0.72)1.804.95
EPS (Diluted)(1.54)(1.60)(0.72)1.754.89
Weighted Avg Shares27.26M28.07M29.3M29.76M29.37M
Weighted Avg Shares (Diluted)27.26M28.07M29.3M30.54M29.76M

Inspire Medical Systems, Inc.

NYSE:INSP

Intrinsic Alpha fair value

Locked

Current Price

$58.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.